coenzyme Q10/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011Permalink
Keep reading
- Everything the graph holds on coenzyme Q10
- Every compound studied against Tumour necrosis factor alpha concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2PFCPBX96ERC0GGWXF8VJNT